Hundreds gathered at the East Side federal complex in Portland on Thursday, where U.S. Sens. Ron Wyden and Jeff Merkley, along with Rep. Suzanne Bonamici held a rally opposing the Affordable Care Act repeal effort.
An OHSU pilot study suggests the over-the-counter antioxidant lipoic acid holds promise in improving the lives of patients with secondary progressive multiple sclerosis.
Today the OHSU Knight Cancer Institute announced that internationally renowned bioengineering and technology expert Mike Heller, Ph.D., will join the institute’s Cancer Early Detection Advanced Research Center, or CEDAR, to lead its technology efforts.
A study of more than 500 cancer survivors found that many years after completing treatment, nearly half of women cancer survivors continued to experience chemotherapy-induced peripheral neuropathy, CIPN.
A first-of-its-kind collaboration between hospital and regional insurance providers provides community-based interventions to support youth whose medical needs are compounded by social problems.